| Dr Joseph Daoko, MD | |
|
2030 W Boulevard, Kokomo, IN 46902-6079 | |
| (765) 454-0200 | |
| Not Available |
| Full Name | Dr Joseph Daoko |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 26 Years |
| Location | 2030 W Boulevard, Kokomo, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316100886 | NPI | - | NPPES |
| 0220299 | Medicaid | NJ |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Vincent Kokomo | Kokomo, IN | Hospital |
| St Vincent Heart Center | Indianapolis, IN | Hospital |
| Woodlawn Hospital | Rochester, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Vincent Medical Group Inc | 7012047640 | 625 |
News Archive
As if expecting mothers didn't have enough to worry about, a new study published in Risk Analysis: An International Journal found that the quantity of delivery complications in hospitals are substantially higher during nights, weekends and holidays, and in teaching hospitals.
Developmental dyslexia is one of the most widespread learning disabilities. Different therapeutic approaches and learning strategies are used to tackle the reading and writing difficulties associated with dyslexia, but to-date it is impossible to cure dyslexia.
The President of the Texas Health Care Association (THCA), Tim Graves, today expressed concern about the growing cumulative pressure on the critical state and federal funding needed to preserve and protect Texas' most vulnerable nursing home residents. Specifically, Graves warned that sharp federal Medicare cuts already put in place by the Obama Administration in late 2009 – as well as those contained within the pending federal health care reform bill – must be a key consideration as state lawmakers begin assessing budgetary priorities in the face of looming state budget deficits.
InSightec Ltd. has announced that the U.S. Food and Drug Administration (FDA) approved a label change for the company's ExAblate 2000 MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with non-hysteroscopically resectable uterine fibroids.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 1 days ago
| Entity Name | St Vincent Physician Services Hospital And Health Care Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669422234 PECOS PAC ID: 9638072184 Enrollment ID: O20040223001092 |
News Archive
As if expecting mothers didn't have enough to worry about, a new study published in Risk Analysis: An International Journal found that the quantity of delivery complications in hospitals are substantially higher during nights, weekends and holidays, and in teaching hospitals.
Developmental dyslexia is one of the most widespread learning disabilities. Different therapeutic approaches and learning strategies are used to tackle the reading and writing difficulties associated with dyslexia, but to-date it is impossible to cure dyslexia.
The President of the Texas Health Care Association (THCA), Tim Graves, today expressed concern about the growing cumulative pressure on the critical state and federal funding needed to preserve and protect Texas' most vulnerable nursing home residents. Specifically, Graves warned that sharp federal Medicare cuts already put in place by the Obama Administration in late 2009 – as well as those contained within the pending federal health care reform bill – must be a key consideration as state lawmakers begin assessing budgetary priorities in the face of looming state budget deficits.
InSightec Ltd. has announced that the U.S. Food and Drug Administration (FDA) approved a label change for the company's ExAblate 2000 MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with non-hysteroscopically resectable uterine fibroids.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 1 days ago
| Entity Name | St Vincent Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144513375 PECOS PAC ID: 7012047640 Enrollment ID: O20100609000045 |
News Archive
As if expecting mothers didn't have enough to worry about, a new study published in Risk Analysis: An International Journal found that the quantity of delivery complications in hospitals are substantially higher during nights, weekends and holidays, and in teaching hospitals.
Developmental dyslexia is one of the most widespread learning disabilities. Different therapeutic approaches and learning strategies are used to tackle the reading and writing difficulties associated with dyslexia, but to-date it is impossible to cure dyslexia.
The President of the Texas Health Care Association (THCA), Tim Graves, today expressed concern about the growing cumulative pressure on the critical state and federal funding needed to preserve and protect Texas' most vulnerable nursing home residents. Specifically, Graves warned that sharp federal Medicare cuts already put in place by the Obama Administration in late 2009 – as well as those contained within the pending federal health care reform bill – must be a key consideration as state lawmakers begin assessing budgetary priorities in the face of looming state budget deficits.
InSightec Ltd. has announced that the U.S. Food and Drug Administration (FDA) approved a label change for the company's ExAblate 2000 MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with non-hysteroscopically resectable uterine fibroids.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Daoko, MD 2030 W Boulevard, Kokomo, IN 46902-6079 Ph: () - | Dr Joseph Daoko, MD 2030 W Boulevard, Kokomo, IN 46902-6079 Ph: (765) 454-0200 |
News Archive
As if expecting mothers didn't have enough to worry about, a new study published in Risk Analysis: An International Journal found that the quantity of delivery complications in hospitals are substantially higher during nights, weekends and holidays, and in teaching hospitals.
Developmental dyslexia is one of the most widespread learning disabilities. Different therapeutic approaches and learning strategies are used to tackle the reading and writing difficulties associated with dyslexia, but to-date it is impossible to cure dyslexia.
The President of the Texas Health Care Association (THCA), Tim Graves, today expressed concern about the growing cumulative pressure on the critical state and federal funding needed to preserve and protect Texas' most vulnerable nursing home residents. Specifically, Graves warned that sharp federal Medicare cuts already put in place by the Obama Administration in late 2009 – as well as those contained within the pending federal health care reform bill – must be a key consideration as state lawmakers begin assessing budgetary priorities in the face of looming state budget deficits.
InSightec Ltd. has announced that the U.S. Food and Drug Administration (FDA) approved a label change for the company's ExAblate 2000 MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with non-hysteroscopically resectable uterine fibroids.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 1 days ago
Leny Philip, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3118 S Lafountain St, Kokomo, IN 46902 Phone: 765-864-4160 Fax: 765-864-4166 | |
Dr. Alok Silodia, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2350 S Dixon Rd Ste 430, Kokomo, IN 46902 Phone: 765-453-1205 Fax: 765-453-6889 | |
Huan Cui, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1907 W Sycamore St, Kokomo, IN 46901 Phone: 765-456-5433 | |
Dr. Dawn Marie Sabau, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3508 S Lafountain St, Kokomo, IN 46902 Phone: 765-453-8181 Fax: 765-453-8565 | |
Julie B Tredemeyer, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3611 S Reed Rd Ste 103, Kokomo, IN 46902 Phone: 765-776-5500 | |
Dr. Imran Ahmed Sethi, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1907 W Sycamore St, Kokomo, IN 46901 Phone: 765-456-5847 | |
Karthik Rao Polsani, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3500 S Lafountain St, Kokomo, IN 46902 Phone: 765-776-3020 Fax: 775-453-8111 |